Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$1.12 - $1.49 $25,648 - $34,121
22,900 Added 78.97%
51,900 $61,000
Q1 2023

May 12, 2023

BUY
$1.19 - $2.19 $34,510 - $63,510
29,000 New
29,000 $43,000
Q4 2019

Feb 12, 2020

SELL
$13.94 - $24.12 $5.87 Million - $10.1 Million
-420,800 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$13.89 - $23.16 $5.84 Million - $9.75 Million
420,800 New
420,800 $6.38 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.